Navigation Links
PBS Special on Health Care Reform
Date:9/8/2009

>

NIGHTLY BUSINESS REPORT will investigate the costs and controversies of employer-provided health care and new coverage requirements many companies are adopting as a means of controlling health care.

NIGHTLY BUSINESS REPORT anchor Susie Gharib said, "Most Americans rely on their employers to pay a large part of their health care expenses. The worry now is whether health care reform will change that. This is a serious financial and emotional issue for everyone."

TAVIS SMILEY will focus on the childhood obesity epidemic, particularly within communities of color. Smiley will examine the causes and effects of childhood obesity and explore ways to address this health care crisis.

"I will be talking to experts to find out what is causing this epidemic and what steps parents, kids and communities can take to get our young people healthy," says host Tavis Smiley.

About NOW ON PBS

Called "fearless about challenging conventional wisdom" by Tom Brokaw and "one of the last bastions of serious journalism on TV" by the Austin American-Statesman, the Emmy-winning PBS weekly newsmagazine NOW ON PBS probes the most important issues facing democracy. NOW is a production of JumpStart Productions, LLC, in association with Thirteen/WNET New York. The show also can be accessed through On-Demand television, audio and video podcasting, and streaming video on the NOW Web site at www.nowonpbs.org.

About TAVIS SMILEY

TAVIS SMILEY is a unique hybrid of news, issues and entertainment, featuring interviews with politicians, entertainers, athletes, authors and other newsmakers. Tavis Smiley was recently named to TIME's list of 100 "Most Influential People in the World." TAVIS SMILEY is produced by The Smiley Group, Inc./TS Media, Inc., in association with
'/>"/>

SOURCE PBS
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
2. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
6. Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenues KEY TO THE CURE
7. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
8. Uninsured community health center patients often have difficulty accessing specialty services
9. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
10. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
11. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at Lulu.com

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...mice, disks placed under the skin kill tumor cells...althDay News) -- A cancer vaccine delivered in a f...in mice, a new study reports. , The method uses...are loaded with tumor-specific antigens and implan...to attack tumors. The Harvard University scientist...
(Date:11/25/2009)... BioSpace.com, the premier r...unveiled the third edition of the BioForest™... Englewood, CO (Vocus) November 25, 2009 --...ce careers and information, unveiled the third edi...morning., , , , ,This regional campaign is a prom...
(Date:11/25/2009)..., SALTLAKECITY,Nov.25/PRNewswire/--dazzlesmile,...C www.optimalhealthscience.com havefileda67-pagefe...azoogle.com,Inc.,JesseWillms,FarendServicesLimited...ththeUnitedStatesDistrictCourtfortheDistrictofUtah...gofdazzlesmile(TM)brandedteethwhiteningproducts,vi...
(Date:11/25/2009)... HOUSTON - Two signaling pathways essential to nor... epidermal growth factor receptor (EGFR) pathways ...asion and metastasis, researchers from The Univers...n the Nov. 25 issue of Molecular Cell . , This ...naling components known to correlate with invasive...
(Date:11/25/2009)...This press release is available in French . , ,...nologies are about to enter the marketplace, thank...imited Partnership (Univalor) and Cognitive Sensin... based in Montreal. , Univalor, which commercial... its affiliated institutions, and CSI have announc...
Breaking Medicine News(10 mins):Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2
... 40%, to 56,000 new cases annually, CDC researcher...) -- The number of Americans newly infected with H...at was previously assumed, U.S.health officials ha..., Using the new method, researchers at the U.S. Ce...
...aw Firm Offers Assistance, Information to People A... Houston, TX (PRWEB) August 2, 2008 ...leman announce the launch of a http://www.tysabri...ysabri, a drug used to treat multiple sclerosis (M...
... new infections in 2006,follows nearly two-year de...w HIV infection,figures scheduled to be released o...and Prevention (CDC) are expected to increase the ...n ongoing,increase in the annual estimated infecti...
...Nasdaq: GXDX ), a specialized laboratory services... and Laurence R. McCarthy, Ph.D. to its Board of,D...am has been elected to,serve as a Class I director... elected to serve as a Class II director of,Genopt...
...ogram launched locally to help people manage the d...hospital admissions among participants. , The fir...s & Balances encourages people with diabetes to co...-cholesterol, an eye exam, and screening for kidne...
...ke reactions to nonionic iodinated contrast materi...nd can be treated safely with commonly used medica...earchers at the University of Michigan Hospitals i...st material to patients and some of these reaction...
Other Medicine News:Health News:Number of New U.S. HIV Infections Gets Revised Upwards 2Health News:Tysabri Lawyers Pulaski & Middleman Launch Web Resource Center for Patients Suffering from Tysabri Side Effects 2Health News:New HIV Infection Figures from CDC to be Announced on Aug. 3 Underscore Need for National AIDS Strategy for the U.S. 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 3Health News:Innovative diabetes program in Bloomington-Normal, Ill., a success 2Health News:Allergic-like reactions to iodinated contrast material treated safely with commonly used medications 2
(Date:11/25/2009)...ordingtoMillenniumResearchGroup(MRG),theglobalauth...ly$3billionUSmarketfortraumafixationdeviceswillcon...erecenteconomicslowdown.MRG,s USMarketsforTraumaDe...hlydynamicoverthenextfiveyears,withcompetitorsintr...gmentsofthetraumafixationmarket,fuelingmarketgrowt...
(Date:11/25/2009)...empraPharmaceuticalsInc.todayannouncedthatPrabhava...lpresentatthePiperJaffray21stAnnualHealthCareConfe...ceHotelinNewYorkCity.Dr.Fernandeswillprovideanover...ramsforthetreatmentofdrug-resistantpathogensinclud...Foundedin2006,CempraPharmaceuticalsisaprivately-he...
(Date:11/25/2009)...ker.comannouncesthatanewmarketresearchreportisavai...-USMarketTrends&Analysis http://www.reportlin...ket-Trends--Analysis.html ,, TheUSintranasaldr...icapplicationsfromthedeliveryofconventionallocalth...ugs.Thefutureofthetechnologyhingesontotheeffective...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 1Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 3H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 1H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 1Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 3
...uced risk of death by 13% (P=0.08), despite inclus...mara therapy , , - In a separate censored ana...o Femara, reduction in risk of death was 19% , ...IG 1-98 trial reinforces starting with Femara as t... , EAST HANOVER, N.J., Dec. 11 New long-term d...
...cember 11 AFFiRiS has started,pre-clinical develo... as,PD01, can be used to target a specific protein...s degenerative neurological disease. Excellent pro...ed the company to file a patent,application and pr...tive,results from external assessments impelled th...
Other Medicine Technology:Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 2Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 3Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 4Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 5Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 6Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 7Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 8AFFiRiS Begins Development of a Parkinson's Vaccine 2AFFiRiS Begins Development of a Parkinson's Vaccine 3
Sterile Coil Packed Pediatric Suction Catheters with SAFE-T-VAC Valve
Sterile Suction Catheters without Control Valve
Sterile Single Loop Suction Catheters with TOUCH-TROL Valve
Catheter Suction 14FR Sterile W/Control Valve
Medicine Products: